Know your World in Just 60 Words!
Read news in 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2021-06-14 16:26:25

The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the United States and Mexico. Additional analyses of the trial are ongoing, according to the company, and will be submitted to peer-reviewed journals for publication.

Covid 19 Update

Headlines

Good News

politics

India

World

Copyright © 2019 Newz Viewz | Created by Communicators and Developed by Seawind Solution Pvt. Ltd.